SAN FRANCISCO (MarketWatch) -- Nastech Pharmaceutical Co. said Friday it has submitted a response to the Food and Drug Administration's office of generic drugs regarding the potential for ...

DUBLIN, Nov. 18, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that its Par Sterile Products business has begun shipping calcitonin salmon injection, USP, multi-dose vials ...

Study Demonstrating that Nastech's Calcitonin-Salmon Nasal Spray is Bioequivalent to Novartis' Miacalcin(R) (Calcitonin-Salmon) Nasal Spray and The abstract presented data from a 199 subject trial ...

Miacalcin is a form of calcitonin which is a hormone that we produce in the body. Calcitonin slows down our bone losses so that our own bone building can get caught up and even increase bone density.

September 23, 2011 (San Diego, California) — Oral recombinant salmon calcitonin tablets are more effective at improving lumbar spine bone mineral density (BMD) after 48 weeks than placebo or a nasal ...

Data showed oral drug licensed from Unigene was as good as nasal spray calcitonin at improving BMD. Tarsa Therapeutics reported positive data from a Phase III study evaluating its once-daily oral ...

—Data Presented at ASBMR 2011 Annual Meeting Show Tarsa's Oral Calcitonin Tablet OSTORA™ Achieved Positive Results on Efficacy Endpoints— The ORACAL study was a Phase III multinational, randomized, ...

BOTHELL — Nastech Pharmaceutical Co. said this week that the U.S. Food and Drug Administration has accepted its new drug application for a nasal spray to treat osteoporosis. While the FDA reviews the ...

Staff reviewers for the U.S. Food and Drug Administration said that a potential increased risk of cancer with drugs containing calcitonin salmon appears plausible. In briefing documents released on ...

PHILADELPHIA, May 29, 2014 /True Blue Tribune/ – Tarsa Therapeutics, Inc. today announced that it raised $7 million to prepare for filing a New Drug Application (NDA) with the U.S. Food and Drug ...